tiprankstipranks
Advertisement
Advertisement

BLRX Stock Latest News

BioLineRx Sets September 23, 2026 Shareholders Meeting to Boost Capital and Approve New Equity Awards
Company AnnouncementsBioLineRx Sets September 23, 2026 Shareholders Meeting to Boost Capital and Approve New Equity Awards
8d ago
6K
BLRX
Is BLRX a Buy, Before Earnings?
PremiumPre-Earnings
Is BLRX a Buy, Before Earnings?
15d ago
BLRX
BioLineRx and Hemispherian Report GLIX1–PARP Synergy in Ovarian Cancer Model, Plan Trial Expansion
PremiumCompany Announcements
BioLineRx and Hemispherian Report GLIX1–PARP Synergy in Ovarian Cancer Model, Plan Trial Expansion
2M ago
6K
BLRX
BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor
PremiumThe Fly
BioLineRx, Hemispherian announces new preclinical data on GLIX1, PARP inhibitor
2M ago
BLRX
BioLineRx Earnings Call: Pipeline Momentum, Profit Squeeze
PremiumCompany Announcements
BioLineRx Earnings Call: Pipeline Momentum, Profit Squeeze
3M ago
BLRX
BioLineRx Kicks Off GLIX1 Clinical Trial as Q1 2026 Loss Widens on Higher R&D Spend
PremiumCompany AnnouncementsBioLineRx Kicks Off GLIX1 Clinical Trial as Q1 2026 Loss Widens on Higher R&D Spend
3M ago
6K
BLRX
BioLineRx reports Q1 EPS 0c vs. (0c) last year
Premium
The Fly
BioLineRx reports Q1 EPS 0c vs. (0c) last year
3M ago
BLRX
Options Volatility and Implied Earnings Moves This Week, May 26 – May 28, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, May 26 – May 28, 2026
3M ago
A
S
BLRX Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
BLRX Upcoming Earnings Report: What to Expect?
3M ago
BLRX
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
PremiumCompany Announcements
BioLineRx and Hemispherian Showcase New GLIX1 Data Ahead of ASCO 2026 as First-in-Human GBM Trial Enrolls
3M ago
6K
BLRX
BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
PremiumCompany Announcements
BioLineRx and Hemispherian Report Strong Preclinical GLIX1 Data in Temozolomide-Resistant Glioblastoma
3M ago
6K
BLRX
BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM
PremiumThe Fly
BioLineRx and Hemispherian report new GLIX1 anti-tumor effect in GBM
3M ago
BLRX
BioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
PremiumCompany AnnouncementsBioLineRx and Hemispherian Dose First Patient in Phase 1/2a GLIX1 Glioblastoma Trial
4M ago
6K
BLRX
BioLineRx, Hemispherian: First patient dosed in Phase 1/2a Study of GLIX1
Premium
The Fly
BioLineRx, Hemispherian: First patient dosed in Phase 1/2a Study of GLIX1
4M ago
BLRX
BioLineRx, Hemispherian initiate clinical trial of GLIX1
Premium
The Fly
BioLineRx, Hemispherian initiate clinical trial of GLIX1
5M ago
BLRX
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
PremiumRatings
BioLineRx: Advancing GLIX1 and Motixafortide Pipeline with Strengthened IP and Legal Position Underpinning Buy Rating and $12 Target
5M ago
BLRX
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
PremiumCompany Announcements
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
5M ago
6K
BLRX
BioLineRx initiates Phase 1/2a study of GLIX1
PremiumThe Fly
BioLineRx initiates Phase 1/2a study of GLIX1
5M ago
BLRX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
5M ago
LAR
MBX
Options Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, March 23 – March 27, 2026
5M ago
AIR
CCL
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
Premium
Company Announcements
BioLineRx Sets March Start for GLIX1 Brain Cancer Trial as 2025 Results Show Leaner R&D-Focused Model
5M ago
6K
BLRX
BioLineRx provides corporate update
Premium
The Fly
BioLineRx provides corporate update
5M ago
BLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >